The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis

Biologic Therapy | Obesity blunts response to tnf therapyПодробнее

The Role of Obesity in Inflammatory Arthritis: Epidemiologic ChallengesПодробнее

Editor's Picks Spotlight: Dr. Lars Erik KristensenПодробнее

Increased Effectiveness of Early Therapy With Anti--Tumor Necrosis Factor-α...Подробнее

EULAR 2020 - Speaker interview: Assessing the effect of increased body mass index to TNF inhibitorsПодробнее

IDEF Educational Series Comorbidities in Psoriasis From Psoriatic Arthritis to ObesityПодробнее

TNF-Inhibitors: “Classic” Biologics for Psoriatic DiseaseПодробнее

How Does Obesity Affect Psoriasis Care?Подробнее

The Metastasis of Obesity to the BrainПодробнее

Weight Loss and Psoriatic Arthritis Clinical Trial Now Enrolling PatientsПодробнее

Obesity and rheumatic diseaseПодробнее

A Psoriatic Arthritis Research UpdateПодробнее

Genetic analysis links obesity to higher rheumatoid arthritis riskПодробнее

A review of paradoxical psoriasisПодробнее

Psoriatic Arthritis: Overcoming Barriers to Improve Patient OutcomesПодробнее

Spondyloarthritis (SpA) and Psoriatic Arthritis (PsA) Treatment UpdateПодробнее

Obesity Reduces Remission Rates in Rheumatoid ArthritisПодробнее

Evolving Therapeutic Strategies for Psoriatic Diseases: Not all IL-23s are Created SimilarПодробнее